Viewing StudyNCT01627067

Bugs

eRecord

Ignite Creation Date: 2024-05-06 @ 12:40 AM

Last Modification Date: 2024-10-26 @ 10:53 AM

Study NCT ID: NCT01627067

Status: TERMINATED

Last Update Posted: 2020-06-19

First Post: 2012-06-21

Brief Title: Exemestane-RAD001-Metformin

Sponsor: MD Anderson Cancer Center

Organization: MD Anderson Cancer Center

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Breast Cancer

Keywords:

Name	View

Metformin	View
Breast Cancer	View
Hormone Receptor Positive Metastatic Breast Cancer	View
Hormone-sensitive	View
Postmenopausal	View
Body Mass Index	View
BMI	View
Everolimus	View
Afinitor	View
RAD001	View
Exemestane	View
Aromasin	View